2023Exhibitor List
0-9|A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z|All
Keyword Search
Find products or contact suppliers? Healthcare+ B2B can help→

Shin Kong Wu Ho-Su Memorial Hospital

health information technology、precision medicine, etc.

Songshan Armed Forces General Hospital

Ear-hook Continuous Physiological Monitoring Wearable Device

Taipei City Hospital

本次展覽以呈現本院「人文科技、全人關懷、智慧醫
療」三大方向為主軸

Taipei Hospital, Ministry of Health and Welfare

Integrated innovative smart technology to facilitate medical care for the people, combined with various smart medical solutions such as smart wards and smart pharmacies, to provide integrated innovative medical services for the public.

Taiwan Adeventist Hospital

Taiwan adventist Hospital exhibits cell therapy, precision medical treatment, including: AI image cell identification and CDC automatic circulating tumor cell system, medical related, including: single-hole minimally invasive 3D endoscopic surgery, spinal minimally invasive surgery, gynecological and urinary sea knife.

Taoyuan Armed Forces General Hospital and Hsinchu Branch

Arthroscopic on the scapholunate ligament can reduce stiffness and would promote to other orthopedic hospital

Taoyuan Armed Forces General Hospital Hsinchu Branch

The ECG (Electrocardiogram) is a commonly used tool in clinical examinations for diagnosing cardiovascular diseases in patients. Currently, the majority of hospitals in Taiwan store DICOM-ECG data in PACS systems for physician interpretation. The QRS detection is typically performed using the XQRS-WFDB algorithm, which demands higher computational costs. Additionally, we have observed that some ECG analysis software available in the market do not perform well in recognizing ECGs with rapid heartbeats. Therefore, we are collaborating with scholars to research and develop improved methods.

Tri-Service General Hospital

innovative medical technology

UnicoCell Biomed Co., Ltd.

For a decade, UnicoCell pioneered stem cell therapy R&D. UnicoCell's Gold Award-winning new stem cell product, ELIXCYTE®, has advanced to the case enrollment phase of Phase III clinical trials for knee osteoarthritis and has reached the unblinding process of Phase II clinical trials for chronic kidney disease, promising innovative treatments for aging-related diseases. The company follows ICH guidelines, holds a 2022 US FDA Master File (MF) for an adipose-derived stem cell bank, a vital raw material for stem cell drug development. UnicoCell has innovated two patented products: 1. Stem Cell Secretome, which is FDA MF-recognized, and is applied for degenerative eye diseases, regenerative medicine, and exosome research. 2. UnicoVial® ultra-low temperature storage, obtained TFDA Class II medical device approval and FDA MF-recognized, applied for cell therapy and biological product storage. UnicoCell aspires to globalize stem cell technology, promote regenerative medicine for aging-related conditions, and ultimately enhance the quality of human life.